Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

GABA and epilepsy: basic concepts from preclinical research.

K Gale1

  • 1Department of Pharmacology, Georgetown University Medical Center, Washington, D.C. 20007.

Epilepsia
|January 1, 1992
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Neurochemical evidence for a nigrotegmental GAbAergic projection.

Brain research·2013
Same author

Effects of transcranial focal electrical stimulation via tripolar concentric ring electrodes on pentylenetetrazole-induced seizures in rats.

Epilepsy research·2013
Same author

Critical research needs for managing coral reef marine protected areas: perspectives of academics and managers.

Journal of environmental management·2012
Same author

Neonatal exposure to phenobarbital potentiates schizophrenia-like behavioral outcomes in the rat.

Neuropharmacology·2012
Same author

Converging PET and fMRI evidence for a common area involved in human focal epilepsies.

Neurology·2011
Same author

Time-dependent increase in basic fibroblast growth factor protein in limbic regions following electroshock seizures.

Neuroscience·2002
Same journal

Responsible use of artificial intelligence in peer-reviewed publications in epilepsy.

Epilepsia·2026
Same journal

Altered autonomic balance drives the increase in cardiac output and arterial pressure during convulsive seizures in nonanesthetized sheep.

Epilepsia·2026
Same journal

Diagnostic yield and copy number variants findings in 219 adult patients with developmental and epileptic encephalopathy.

Epilepsia·2026
Same journal

Prolonged fenfluramine use in open-label studies of Dravet or Lennox-Gastaut syndromes: Long-term safety, tolerability, patient global functioning, and considerations for interpreting effectiveness.

Epilepsia·2026
Same journal

Electrocardiography characteristics and long-term mortality in people with epilepsy from a resource-poor community.

Epilepsia·2026
Same journal

Factors associated with rapid pediatric acute seizure emergency treatment: Quality Improvement in Time to Treat Status Epilepticus baseline cohort.

Epilepsia·2026
See all related articles

Enhancing gamma-aminobutyric acid (GABA) transmission can control epileptic seizures. Different brain regions respond uniquely to GABAergic drugs, with boosting GABA availability showing promise for safer treatments.

Area of Science:

  • Neuroscience
  • Pharmacology
  • Epilepsy Research

Background:

  • Gamma-aminobutyric acid (GABA) is the primary inhibitory neurotransmitter in the central nervous system.
  • Dysregulation of GABAergic signaling is implicated in the pathophysiology of epileptic seizures.
  • Pharmacological strategies to modulate GABA transmission are crucial for epilepsy treatment.

Purpose of the Study:

  • To investigate the role of GABA transmission in controlling convulsive epileptic seizures.
  • To compare the effects of a direct GABAA receptor agonist (muscimol) with a GABA-elevating agent (gamma-vinyl GABA, GVG) in animal seizure models.
  • To explore regional differences in the brain's response to GABAergic modulation.

Main Methods:

  • Utilized animal models of convulsive seizures.

Related Experiment Videos

  • Administered muscimol, a direct GABAA receptor agonist.
  • Administered gamma-vinyl GABA (GVG, vigabatrin), a GABA-elevating agent.
  • Compared the anticonvulsant effects and potential side effects of these agents in specific brain regions.

    • Main Results:

    • Evidence suggests specific brain regions where enhanced GABA transmission is anticonvulsant, while others show anticonvulsant effects from GABA transmission blockade.
    • Distinct regional effects were observed between muscimol and GVG, potentially due to varying endogenous GABA levels.
    • Direct postsynaptic GABA receptor stimulation (muscimol) can cause abnormal symptoms, unlike GVG's enhancement of presynaptic GABA availability.

    Conclusions:

    • The efficacy and side effect profile of GABAergic drugs depend on the brain region and mechanism of action.
    • Enhancing endogenous GABA availability, as with GVG, may offer a safer approach by utilizing physiological pathways.
    • Future epilepsy drug development should prioritize strategies that increase endogenous GABA availability for improved seizure control and reduced side effects.